SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (69)8/28/2006 12:02:40 PM
From: Mike McFarland   of 210
 
If there isn't a deal with Curis, maybe there
soon will be. At the rate that Infinity is
collecting cash, 70-75m from dpi, 70m from Medi
they ought to be able to swing something if
cris has a patent or something they need.

There was a hedgehog screening patent issued
last Spring by Curis, might be worth looking at.
Of course, Infinity has their molecule, so maybe
they don't need Curis anyway, the presentation
they just made addressed that a little.

Nice to see it up, but I'd rather have had them
do this deal after my shares convert. Still, it
would be foolish for infi shareholder's to walk
away from the 70-75m that dpi is giving them--
totally unencumbered.

.......................
I looked at the presentation again, they will aslo
have something to say about 504 in November, you can
put 11/7/6 on your calendar and watch for a PR
that week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext